Proteomic Profiling to Detect Fatty Liver Disease
Friday, May 22, 2009
Fatty liver disease, which can in some case progress to fibrosis and cirrhosis, is an increasingly recognized complication of obesity. Currently, characterization of fatty liver disease is dependent on a liver biopsy.
In a paper appearing this month in GUT, Trak-Smayra and colleagues from the Centre de recherche Biomédical Bichat Beaujon, Paris, France, used SELDI-TOF ProteinChip profiling to detect fatty liver disease in eighty obese non-alcoholic patient candidates for bariatric surgery and who were devoid of hepatitis B and C infection. Proteomic profiles were compared to liver tissue samples.
Three peaks were detected in the proteomic profile (double charged ions of alpha- and beta-haemoglobin subunits), the intensity of which significantly increased according to the severity of the liver lesions and returned to normal after bariatric surgery.
These findings suggest that novel blood tests may be helpful in identifying and characterizing the extent of fatty liver disease in obese patients.
AMS
Edmonton, Alberta
Saturday, May 23, 2009
Hi, nice posts there 🙂 thank’s for the interesting information
Sunday, May 24, 2009
This really is interesting, we may be able to screen patients and offer the ones with sick livers bariatric surgery. I have not seen any thing using BMI to predict liver disease or syndome X. Do you know of any other way to predict liver disease.